ITC Rubber-Stamps Update in Obscure Drug Components Case
Published Date: 9/17/2025
Notice
Summary
The U.S. International Trade Commission has decided to let a change in a legal complaint about certain drug products with C-Type Natriuretic Peptide variants move forward. This affects companies involved in making or selling these drugs and could impact ongoing investigations or legal actions. No new delays or costs were announced, so things are rolling as planned!
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13151 — Certain Heavy Machinery and Components Thereof; Notice of Institution of Investigation
Caterpillar Inc. has asked the U.S. International Trade Commission to investigate certain imported heavy machinery and parts that might be using their patented technology without permission. If the investigation finds problems, it could lead to orders stopping these products from entering or being sold in the U.S., which could shake up the market soon. This all kicked off officially on June 25, 2026, so keep an eye out for changes that might affect companies and buyers.
2026-13128 — Certain Photovoltaic Trunk Bus Cable Assemblies and Components Thereof; Notice of Final Determination Finding a Violation of Section 337; Issuance of a Limited Exclusion Order; Termination of Investigation
The U.S. International Trade Commission found that Voltage, LLC and its Chinese partner broke patent rules by selling certain solar panel cable parts in the U.S. To stop this, the Commission issued a limited ban on these products and requires a 100% cash bond on imports during review. This means Voltage’s infringing products can’t enter the U.S. market, protecting Shoals Technologies and encouraging fair competition.
2026-12996 — Choline Salts From China; Institution of Antidumping and Countervailing Duty Investigations and Scheduling of Preliminary Phase Investigations
The U.S. is launching investigations to see if cheap choline salts from China are hurting American businesses by being sold unfairly or getting government help. If the claims are true, extra taxes might be added to these imports to protect U.S. companies. The first big decision is due by August 10, 2026, so things are moving fast!
2026-12768 — Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
The U.S. International Trade Commission got a complaint about certain adjustable child carriers and their parts, claiming some imports and sales might break trade rules. They want the public to share thoughts on how this could affect everyone, especially families and businesses. This could lead to new rules stopping some products from being sold in the U.S., so keep an eye out for updates soon!
2026-12777 — N-Cyclohexylbenzothiazole-2-Sulfenamide (“CBS”) From China; Determinations
The U.S. government found that imports of a chemical called CBS from China might be hurting American businesses by being sold too cheaply or getting unfair help from the Chinese government. Because of this, they’re starting a big investigation to decide if special taxes or rules should be put in place. This affects companies that make or use CBS and could lead to changes in prices or import rules soon.
2026-12850 — Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
The U.S. International Trade Commission got a complaint about certain skin treatment devices possibly breaking import rules. Companies from several countries, including the U.S., Israel, and Europe, are involved. The Commission wants your thoughts on how this might affect the public before deciding on possible bans or restrictions, with a 60-day review period ahead.
Previous / Next Documents
Previous: 2025-17922 — Advisory Circular No. 450.169-1A, Launch and Reentry Collision Avoidance Analysis
The FAA wants to update its guide for rocket launch and reentry teams on how to avoid collisions during their missions. Now, some commercial space operators working with NASA can get collision checks from two NASA groups, not just one military squadron. This change helps speed up approvals and keeps space missions safe without extra costs or delays.
Next: 2025-17925 — Self-Regulatory Organizations; Cboe BZX Exchange, Inc.; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change To Amend Rule 11.23 To Explicitly Provide That the Exchange May Extend the Quote-Only Period for an Initial Public Offering Auction Where a Derivative Security Fails To Meet the Exchange's Listing Qualification Requirements as Set Forth in Exchange Rule 14.11
Cboe BZX Exchange is updating its rules to clearly say it can extend the 'quote-only' period during an IPO auction if a new derivative security doesn’t meet listing requirements. This change helps the Exchange manage IPOs better and keeps things fair for traders. It’s effective immediately, so anyone involved in IPO auctions on Cboe BZX should take note!